Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes
Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths
One product is being pulled from the market, and the other is receiving updated instructions for use.
AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs
Researchers developed several new AI models that could guide the management of patients with non-valvular atrial fibrillation. There is still some work to do in terms of accuracy, but they already appear to outperform the traditional risk scores being used today.
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH.
Philips pulls endovascular devices from market after safety issues prompt Class I recall
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.

Viagra may worsen abdominal aortic aneurysms, new research shows

While additional research is still needed, these findings suggest that sildenafil may need to be limited among patients with a history of abdominal aortic aneurysms.

An industry first: FDA authorizes marketing of laser-assisted IVC filter removal device

The Philips CavaClear Laser Sheath earned the agency’s breakthrough device designation back in July.

FDA approves rivaroxaban for treating, preventing blood clots in pediatric patients

The direct oral anticoagulant is now approved for 11 different indications.

CDC now recommends Moderna, Pfizer/BioNTech COVID-19 vaccines over Johnson & Johnson’s due to risk of fatal blood clots

Johnson & Johnson’s vaccine has been associated with an elevated risk of thrombosis with thrombocytopenia syndrome.

What happens when TAVR patients also require a peripheral vascular intervention

It does increase certain risks, researchers found—but it can also be a valuable treatment option.

Cardiac imaging specialists receive more than $20M in new funding

The company's new imaging platform simultaneously performs intravascular ultrasound and optical coherence tomography, the two most commonly used modalities.

How treatment decisions can impact young adults with PAD and advanced femoropopliteal disease

The new study, published in the Journal of Vascular Surgery, evaluated outcomes after bypass surgery and endovascular therapy.

A key difference between stroke symptoms for men and women

The study included data from more than 580,000 patients.

Vascular & Endovascular

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs

ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

Philips pulls endovascular devices from market after safety issues prompt Class I recall